Breaking News
September 20, 2018 - Potential drugs to treat neurodegenerative diseases garner $3 million grant
September 20, 2018 - Processing speed important to higher order cognitive function in multiple sclerosis patients
September 20, 2018 - Helping a patient survive a hurricane
September 20, 2018 - Tafamidis Treats Transthyretin Amyloid Cardiomyopathy
September 20, 2018 - Low academic achievement can lead to drug abuse decades later, research finds
September 20, 2018 - Study identifies stem cell that gives rise to new bone, cartilage in humans | News Center
September 20, 2018 - Celltrion and Emory University sign ‘Incubation’ agreement to develop new drug candidates for atherosclerosis
September 20, 2018 - TGen and PNOC take part in launch of NIH-supported Kids First Data Resource Portal
September 20, 2018 - Could Household Cleaners Make Your Kid Fat?
September 20, 2018 - Addiction nonprofit makes searching for services simple
September 20, 2018 - We are bombarded by thousands of diverse species and chemicals | News Center
September 20, 2018 - Experts to Present Prostate Cancer Advances at Patient Summit
September 20, 2018 - Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia
September 20, 2018 - Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA
September 20, 2018 - Study could allow doctors to screen patients at risk from Aspergillus
September 20, 2018 - Emergex signs MoU with Brazil’s Fiocruz for development of viral vaccines
September 20, 2018 - The ‘real you’ is a myth – we constantly create false memories to achieve the identity we want
September 20, 2018 - Researchers describe cell mechanism that optimizes proteins production in stressful situations
September 20, 2018 - Cell Medica successfully doses first patient with CMD-501 targeting pediatric neuroblastoma
September 20, 2018 - Senators unveil legislation to protect patients against surprise medical bills
September 20, 2018 - Study provides insights into development of special-purpose cosmetic products
September 20, 2018 - Research shows enlarged genotype-phenotype correlation for three-base pair deletion in NF1
September 20, 2018 - 91% of people around the world believe medical research will result in dementia cure
September 20, 2018 - DePuy Synthes introduces CONCORDE LIFT Expandable Interbody Device at EUROSPINE 2018
September 20, 2018 - Manx Telecom unveils MT clearSound that improves clarity of mobile phone calls
September 20, 2018 - Mediterranean-style diet appears to reduce stroke risk in women
September 20, 2018 - AbbVie Announces Patient-Reported Outcomes Data from Three Pivotal Phase 3 Studies of Risankizumab, Showing Significant Improvements in Health-Related Quality of Life for Patients with Psoriasis
September 20, 2018 - Characterization of pregnancy microbiome reveals variations in bacterial diversity
September 20, 2018 - New guidance for treatment of bone loss in hematologic stem cell transplant Recipients
September 20, 2018 - Experts to present research on prevention, management of dysphagia at international conference
September 20, 2018 - New study focuses on two-way gene switches controlling gene activity
September 20, 2018 - Zika virus could become a weapon against brain cancer
September 20, 2018 - Home-based video game exercises can reduce chronic low back pain in older people, study finds
September 20, 2018 - Investigators find that bile acids reduce cocaine reward
September 20, 2018 - Cannabinoid drugs reduce perceived unpleasantness of painful stimuli and increase tolerance
September 20, 2018 - Health care companies’ data could enable more accurate flu season forecasts
September 20, 2018 - Geroscience takes center stage in Journal of the American Medical Association
September 20, 2018 - Ambient Particulate Matter Linked to Emergency Asthma Care
September 20, 2018 - Patient satisfaction with plastic surgery—it’s the surgeon, not the practice
September 20, 2018 - Medicine is a team sport – and that’s exactly how it should be
September 20, 2018 - Logos Biosystems releases new electrophoretic tissue clearing system with twice the features in half the space
September 20, 2018 - Novel micro-platform reveals never-before-seen behaviors of cancer cells
September 20, 2018 - PAREXEL partners with Datavant to enhance clinical study design and generate real-world evidence
September 20, 2018 - Robert Koch Institute publishes new data on allergies, mental health problems, and accident injuries
September 20, 2018 - Study finds higher readmission rates in for-profit hospitals
September 20, 2018 - Encouraging youth to do strength-based exercises could help tackle child obesity
September 20, 2018 - Sleep apnea, congenital heart disease in hospitalized infants strongly associated with death
September 20, 2018 - Researchers find way to map mysterious content of non-coding RNA
September 20, 2018 - Air Pollutants Reach Placenta, Might Harm Fetus: Study
September 20, 2018 - Sleep apnea, congenital heart disease may be deadly mix for hospitalized infants
September 20, 2018 - My relative has cancer, should I worry? Encouraging cascade genetic testing
September 20, 2018 - Investigators determine specific treatable traits that can predict future asthma attacks
September 20, 2018 - More doctor visits can lower risk of suicide attempts in fibromyalgia patients
September 20, 2018 - Computer avatars play role in diagnosis of dementia
September 20, 2018 - Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer
September 20, 2018 - ASPREE trial explores whether low dose aspirin can prolong good health in elderly people
September 20, 2018 - ATS publishes new guideline focused on weight loss strategies for sleep apnea patients
September 20, 2018 - The Current issue of “The view from here” is concerned with Drug Delivery
September 19, 2018 - Sleep apnea could favour tumor growth at young ages
September 19, 2018 - Stealth vaping fad hidden from parents, teachers
September 19, 2018 - Witnessing school violence linked to later risk of psycho-social and academic impairment
September 19, 2018 - Common household cleaners could make children overweight by changing gut microbiota
September 19, 2018 - Salk research in yeast leads to serendipitous finding about hypomyelinating leukodystrophy
September 19, 2018 - Study: Overweight or obese women may have increased risk of urinary incontinence
September 19, 2018 - Study shows how cellular waste disposal processes also promote inflammation
September 19, 2018 - New multidisciplinary microsurgery microscope, PROVIDO, introduced by Leica
September 19, 2018 - Phase 2b STORM Data Evaluating Selinexor in Patients with Penta-Refractory Multiple Myeloma Presented at the Society of Hematologic Oncology 2018 Annual Meeting
September 19, 2018 - Decisions recruiting gut feelings seen as reflection of true self, more assuredly held, study says
September 19, 2018 - How AI can improve end-of-life care
September 19, 2018 - UNIST and Ulsan initiate research collaboration to develop human organs-on-chips
September 19, 2018 - Study highlights key role of migrating shoals of fish in sustaining deep-ocean microorganisms
September 19, 2018 - Disagreeable individuals can benefit most from behaving more compassionately, finds study
September 19, 2018 - Janssen Submits New Drug Application to U.S. FDA Seeking Approval of Erdafitinib for the Treatment of Metastatic Urothelial Cancer
September 19, 2018 - Neuroplasticity is increased but dysregulated in the aging brain, study finds
September 19, 2018 - Suicide: A public health crisis
September 19, 2018 - Infants using popular anti-reflux medicines are not at increased risk of lung infections
September 19, 2018 - Stanford team will participate in NIH-funded study of tobacco policies | News Center
September 19, 2018 - Women with high levels of anti-Müllerian hormone more likely to develop breast cancer
September 19, 2018 - Researchers use larval zebrafish model to reveal role of locus coeruleus in anesthesia
September 19, 2018 - Effects of prematurity found to be more severe for the brains of males than females
Genetic checking out is helping set secure dose of not unusual blood thinner

Genetic checking out is helping set secure dose of not unusual blood thinner

image_pdfDownload PDFimage_print

Warfarin is a blood thinner this is recurrently prescribed to sufferers to stop life-threatening blood clots. In spite of its longtime use, warfarin stays tough to dose as a result of an individual’s genetic make-up influences how the drug is processed within the frame. An excessive amount of warfarin may cause inside bleeding; too little warfarin fails to stop blood clots.

Now, a brand new find out about led via Washington College Faculty of Medication in St. Louis presentations that dosing warfarin (Coumadin and others) is more secure—generating fewer opposed occasions equivalent to hemorrhage—when key components of a affected person’s genetic make-up are regarded as.

The analysis, printed Sept. 26 within the Magazine of the American Clinical Affiliation, experiences effects from the medical trial referred to as GIFT (Genetics Informatics Trial of Warfarin to Save you Deep Venous Thrombosis).

“Physicians were prescribing warfarin because the Eisenhower management,” mentioned first writer Brian F. Gage, MD, a professor of medication at Washington College Faculty of Medication in St. Louis. “It is a broadly used anticoagulant, however it reasons extra primary opposed occasions than another oral drug. 1000’s of sufferers finally end up within the emergency division or medical institution on account of warfarin-induced bleeding. However we proceed to prescribe it as a result of it’s extremely efficient, reversible and affordable. So our function is to make warfarin more secure. GIFT confirmed that precision-medicine according to medical elements and 3 genes improves the security of beginning warfarin treatment.”

Sufferers within the trial have been randomly assigned to one among two teams. One team won warfarin dosing according to same old elements equivalent to age, peak and weight; the second one team used to be dosed according to those medical elements plus genetic variants. Collaborating websites within the trial integrated Washington College Faculty of Medication, Clinic for Particular Surgical procedure in New York, Intermountain Healthcare, College of Utah, and Rush College Clinical Middle.

Of the 789 sufferers who have been dosed within the conventional approach, 116 skilled no less than one opposed tournament (14.7 p.c). Of the 808 sufferers whose warfarin dosing used to be guided via genetic checking out, 87 skilled an opposed tournament (10.eight p.c). In comparison with sufferers receiving conventional warfarin dosing, sufferers dosed with the genetic means had a 27 p.c relief in opposed occasions, which used to be statistically other. The opposed occasions have been bleeding, formation of blood clots within the veins and warfarin overdoses. No affected person died all through the trial.

Previous research having a look at whether or not genetic checking out may give a boost to warfarin dosing had produced conflicting effects. Alternatively, those research have been smaller and regarded as fewer genes than GIFT. GIFT enrolled 1,600 sufferers age 65 and older at top possibility of blood clots as a result of they underwent hip- or knee-replacement surgical procedures.

Not like prior research, GIFT took under consideration genetic variants in 3 genes for 11 days of warfarin treatment. Genetic variants have been assessed on a industrial platform known as GenMarkDx. Variants in a single gene have an effect on nutrition Ok recycling. Variants in any other gene have an effect on warfarin sensitivity. Variants within the 3rd gene modify warfarin metabolism within the liver and will purpose an overdose if the dose isn’t adjusted quickly sufficient.

“There are further genetic variants that can lend a hand to lead warfarin dosing, particularly amongst sufferers with African ancestry,” Gage mentioned. At some point, we are hoping to quantify how those variants have an effect on warfarin.”

Gage additionally famous how health-care prices relate to dosing warfarin in a genetically guided approach. “Even if genetic checking out is dearer than medical dosing, the price is falling,” he mentioned. “In our find out about, we estimated that genetic checking out prices not up to $200 in line with particular person, which is not up to one month of a more moderen anticoagulant.”


Discover additional:
Genetically guided warfarin dosing lowers possibility of a few opposed occasions

Additional info:
Gage BF, Bass AR, Lin H, Woller SC, Stevens SM, Al-Hammadi N, Li J, Rodriguez Jr. T, Miller JP, McMillin GA, Pendleton RC, Jaffer AK, King CR, DeVore B, Porche-Sorbet R, Napoli L, Merritt Ok, Thompson AM, Hyun G, Anderson JL, Hollomon W, Barrack RL, Nunley RM, Moskowitz G, Davila-Roman V and Eby CS for the GIFT investigators. Impact of genotype-guided warfarin dosing on medical occasions and anticoagulation regulate amongst sufferers present process hip or knee arthroplasty: the GIFT randomized medical trial. Magazine of the American Clinical Affiliation. Sept. 26, 2017. DOI: 10.1001/jama.2017.11463

Magazine reference:
Magazine of the American Clinical Affiliation

Supplied via:
Washington College Faculty of Medication

Tagged with:

About author

Related Articles